Revance Therapeutics, Inc. - COM (RVNC)

Q1 2014 13F Holders as of 3/31/2014

Type / Class
Equity / COM
Number of holders
65
Total Shares
11.8M
Shares change
+11.8M
Total reported value, excl. options
$373M
Value change
+$373M
Put/Call ratio
0
Number of buys
65
Number of sells
0
Price
$31.50
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.